Key result
Elevated BMI and fasting glucose independently predict high TyG-BMI in dysglycemic heart failure patients.
Why the study?
The clinical and biochemical factors independently associated with TyG-BMI tertiles and their diagnostic thresholds needed to be identified in prediabetic and diabetic HF patients on SGLT2 inhibitor therapy to inform individualized, metabolically guided cardiovascular risk management.
Cross-Sectional (n=89)
In heart failure patients with prediabetes or diabetes treated with SGLT2 inhibitors, fasting plasma glucose and body mass index are the primary parameters predicting the triglyceride-glucose-body mass index (TyG-BMI).
Answers are grounded in this paper and cite their sources.
Does not support practice change in SGLT2i-treated HF; leaves open prospective validation of metabolic targets.
Objective: The present study was therefore designed to identify the clinical and biochemical factors independently associated with triglyceride–glucose–body mass index (TyG-BMI) tertiles in prediabetic and diabetic heart failure (HF) patients receiving sodium–glucose cotransporter-2 (SGLT2) inhibitor therapy, and to determine the diagnostic thresholds of these factors, with the aim of informing more individualized, metabolically guided cardiovascular risk management. Materials and Methods: This cross-sectional study included 89 patients with prediabetes or Diabetes Mellitus (DM). All patients had a diagnosis of HF and were receiving SGLT2 inhibitor treatment. Body mass index (BMI), fasting plasma glucose (FPG), and serum triglyceride levels were evaluated, and the TyG-BMI was calculated in prediabetic and diabetic patients. Results: The model was completed in three stages, and BMI (p < 0.001) in Stage 1, BMI (p = 0.001) and FPG (p = 0.020) in Stage 2, and similarly, BMI (p = 0.003) and FPG (p = 0.034) in Stage 3 predicted TyG-BMI. The optimal cut-off value for the BMI parameter was found to be >26.12 kg/m2, with a sensitivity of 90.00 and a specificity of 100.00, while the optimal cut-off value for the FPG parameter was found to be >123.6 mg/dL, with a sensitivity of 50.00 and a specificity of 79.31. Discussion: We found FPG and BMI to be the most important prognostic parameters in predicting TyG-BMI.
No takes yet. Share an insight, caveat, or question.
AY et al. (2026) conducted a cross-sectional in Heart failure with prediabetes or diabetes mellitus (n=89). Body mass index (BMI) and fasting plasma glucose (FPG) was evaluated on Prediction of triglyceride–glucose–body mass index (TyG-BMI) tertiles (p=0.003). BMI and fasting plasma glucose predicted TyG-BMI in dysglycemic heart failure patients on SGLT2 inhibitors.
Synapse has enriched 10 related papers. Consider them for comparative context: